Table 3 Differences in genotypic and allelic distributions between controls and CAD patients.
CAD n (%) | Control n (%) | versus | p | |
|---|---|---|---|---|
rs247616 | ||||
CC | 178 (45.2) | 60 (39.2) | CT + TT | 0.208 |
CT | 173 (43.9) | 76 (49.7) | CC | 0.192 |
TT | 43 (10.9) | 17 (11.1) | CC | 0.623 |
CC + CT | 351 (89.1) | 136 (88.9) | TT | 0.947 |
C | 529 (67.1) | 196 (64.1) | T | 0.334 |
T | 259 (32.9) | 110 (35.9) | C | 0.334 |
rs12720922 | ||||
AA | 12 (3.0) | 5 (3.3) | AG + GG | 0.893 |
AG | 129 (32.8) | 42 (27.4) | AA | 0.662 |
GG | 253 (64.2) | 106 (69.3) | AA | 0.992 |
AA + AG | 141 (35.8) | 47 (30.7) | GG | 0.263 |
A | 153 (19.4) | 52 (17.0) | G | 0.357 |
G | 635 (80.6) | 254 (83.0) | A | 0.357 |
